MedPath

Phase II study of intensive chemotherapy in treating pediatric patients with newly diagnosed cranial nongerminomaous germ cell tumor

Phase 2
Completed
Conditions
Cranial nongerminomatous germ cell tumor
Registration Number
JPRN-UMIN000002398
Lead Sponsor
Japanese Pediatric Brain Tumor Consortiun
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Has double cancer. Has cardiac disease for which treatment is necessary.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath